Sanofi

News

Sanofi's RA drug Kevzara approved in Europe

Sanofi’s next-generation rheumatoid arthritis drug Kevzara has been approved in Europe, giving a new option for patients who are intolerant to other treatments.

News

Data synchronization of health book between smartwatch and smartphone in male hands

Parexel and Sanofi collaborate on wearables study

Study will focus on PAREXEL's Perceptive MyTrials platform for gathering wearables data.

Partner Content

Partner Content

What's Pharma’s next step? – AI Pharma Innovation Summit

Real World Application of AI in Pharma's R&D

News

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien...

Companies awaiting CV outcomes trial, and court decision in patent case

News

Novo hopes hypoglycaemia data will boost Tresiba

Lower severe hypo risk compared with Lantus - but no cardiac benefit.

News

Sanofi, Regeneron aim to undercut rivals with new RA drug

New drug will be sold at around 30% discount to rivals.

Sanofi's RA drug Kevzara approved in Europe

Parexel and Sanofi collaborate on wearables study

What's Pharma’s next step? – AI Pharma Innovation Summit

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien...

Novo hopes hypoglycaemia data will boost Tresiba

Sanofi, Regeneron aim to undercut rivals with new RA drug

Beacon's XLRP gene therapy set for filing after phase 3 win

Discover a new era of healthcare panel engagement: Grounded ...

Sanofi

Editor's Picks